Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lynparza Recommended for Approval in EU by CHMP for BRCA-Mutated Metastatic Pancreatic Cancer

americanpharmaceuticalreviewJune 10, 2020

Tag: Lynparza , CHMP , AstraZeneca , Merck , Pancreatic cancer

PharmaSources Customer Service